GSK3 Assay Substrate Design for 4E-BP1 Phosphorylation Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for glycogen synthase kinase 3 (GSK3) assays lack effective substrates for detecting GSK3 activity and identifying modulators, particularly for phosphorylating eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), which is crucial for understanding cellular signaling pathways.

Innovation Solution

Development of specific 4E-BP1 glycogen synthase kinase 3 substrates, including peptides and nucleic acid sequences that promote specific interaction with GSK3, allowing for the detection of phosphorylation events, which are used in assays to identify GSK3 modulators and assess enzyme activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional substrate methods are used for GSK3 assays, then the assay can be performed, but the detection accuracy and ability to identify modulators is insufficient

Engineering Contradiction:
Improvedetection accuracy of GSK3 activityVSAvoidability to identify modulators
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the substrate parameter from conventional peptides to specifically designed 4E-BP1-derived peptides with defined phosphorylation sites. This parameter change enables specific detection of GSK3 activity and improves the ability to identify modulators through enhanced measurement precision and reliability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces 4E-BP1 as an intermediary substrate that specifically interacts with GSK3. This intermediary enables indirect detection of GSK3 activity through phosphorylation events, improving both detection accuracy and modulator identification capability

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If specific 4E-BP1 substrates are developed, then detection accuracy improves, but the complexity of assay development increases

Engineering Contradiction:
Improvedetection accuracy of phosphorylation eventsVSAvoidcomplexity of assay development
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the 4E-BP1 protein into specific peptide substrates containing defined phosphorylation sites. This segmentation allows focused detection on specific phosphorylation events, improving measurement precision while managing assay complexity through modular substrate design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by designing peptides with specific phosphorylation sites at defined locations. This localized modification enables specific detection of GSK3 activity at particular sites, improving detection accuracy without requiring complex entire-protein assays

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate detection of GSK3 activity and identification of modulators through specific interaction and phosphorylation detection, facilitating the study of physiological pathways and the development of commercial kits for practical application.

Implementation Method 1

Enzymes known as glycogen synthase kinase 3 are serine/threonine protein kinases that catalyze the addition of phosphate molecules on certain serine and threonine amino acid residues in target protein substrates within cells.

Methodology Applied
Scientific EffectPhosphorylation: Chemical Bonding

Data Source

PatentUS8323919B2Assay methods for identifying glycogen synthase kinase 3 modulators
Publication Date: 2012.12.04 REVVITY HEALTH SCI CANADA INC
  • US8323919B2 patent drawing
  • US8323919B2 patent drawing
  • US8323919B2 patent drawing

AI summary

Methods and compositions for glycogen synthase kinase 3 assays continue to be required for detection of glycogen synthase 3 kinase, assessment of glycogen synthase 3 kinase activity and identification of modulators of glycogen synthase 3 kinase. Methods and compositions for glycogen synthase kinase 3 assays are provided herein based on the discovery of a previously unknown interaction between glycogen synthase 3 kinase and eukaryotic translation initiation factor 4E-binding protein 1 which serves as a substrate for glycogen synthase kinase 3-alpha and glycogen synthase kinase 3-beta.